{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:00:18Z","timestamp":1784098818285,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.apradiso.2014.11.006","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T21:07:22Z","timestamp":1415740042000},"page":"91-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Evaluation and comparison of a new DOTA and DTPA - bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models"],"prefix":"10.1016","volume":"96","author":[{"given":"Priscilla B.","family":"Pujatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Finucane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantelle D.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome C.","family":"Burnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerly F.M.","family":"Pasqualoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair","family":"Mengatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine B.","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane K.","family":"Sosabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apradiso.2014.11.006_bib1","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2967\/jnumed.111.094375","article-title":"Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors","volume":"52","author":"Abiraj","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/pros.21434","article-title":"Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates","volume":"72","author":"Beer","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.apradiso.2014.11.006_bib3","first-page":"1650","article-title":"Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy","volume":"43","author":"Breeman","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/js960177k","article-title":"Prediction of distribution coefficient from structure. 1. Estimation method","volume":"86","author":"Csizmadia","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.apradiso.2014.11.006_bib5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s00259-006-0356-3","article-title":"Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours","volume":"34","author":"de Visser","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2967\/jnumed.111.087999","article-title":"PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference","volume":"52","author":"Fani","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1677\/ERC-08-0316","article-title":"High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications","volume":"16","author":"Fleischmann","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"10","key":"10.1016\/j.apradiso.2014.11.006_bib8","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2967\/jnumed.114.141242","article-title":"N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging","volume":"55","author":"Gourni","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nucmedbio.2014.03.014","article-title":"PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists","volume":"41","author":"Jamous","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2014.11.006_bib10","first-page":"1144","article-title":"177Lu-AMBA: synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer","volume":"47","author":"Lantry","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.nucmedbio.2010.04.016","article-title":"Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu\u2013NO2A\u2013(X)-BBN(7\u201314)NH2], in a prostate tumor xenografted mouse model","volume":"37","author":"Lane","year":"2010","journal-title":"Nucl. Med. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.apradiso.2014.11.006_bib12","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s00259-011-2014-7","article-title":"Radiolabelled peptides for oncological diagnosis","volume":"39","author":"Laverman","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib13","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1088\/0031-9155\/54\/24\/007","article-title":"The impact of respiratory motion on tumor quantification and delineation in static PET\/CT imaging","volume":"54","author":"Liu","year":"2009","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.apradiso.2014.11.006_bib14","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2967\/jnumed.113.121533","article-title":"A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer","volume":"54","author":"Liu","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib15","first-page":"823","article-title":"Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs","volume":"46","author":"Maina","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib16","first-page":"1152","article-title":"Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation","volume":"59","author":"Markwalder","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.apradiso.2014.11.006_bib17","doi-asserted-by":"crossref","first-page":"26062","DOI":"10.1074\/jbc.272.41.26062","article-title":"Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors","volume":"272","author":"Mantey","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.apradiso.2014.11.006_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00259-010-1596-9","article-title":"Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours","volume":"38","author":"Mansi","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib19","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1021\/jm4010237","article-title":"Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: synthesis and preclinical comparison","volume":"56","author":"Marsouvanidis","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.apradiso.2014.11.006_bib20","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2967\/jnumed.109.064444","article-title":"177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression","volume":"50","author":"Maddalena","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00259-011-1992-9","article-title":"Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts","volume":"39","author":"Malmberg","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.nucmedbio.2012.01.002","article-title":"Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics","volume":"39","author":"Okarvi","year":"2012","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2014.11.006_bib23","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s00259-011-1818-9","article-title":"Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607","volume":"38","author":"Ocak","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-2999(97)01527-6","article-title":"Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes","volume":"343","author":"Pradhan","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.apradiso.2014.11.006_bib25","first-page":"310","article-title":"Novel series of (177)Lu-labeled bombesin derivatives with amino acidic spacers for selective targeting of human PC-3 prostate tumor cells","volume":"55","author":"Pujatti","year":"2011","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib26","first-page":"1139","article-title":"Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[d-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14)","volume":"8","author":"Reubi","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.apradiso.2014.11.006_bib27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00259-002-0794-5","article-title":"Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting","volume":"29","author":"Reubi","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.apradiso.2014.11.006_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.nucmedbio.2005.05.005","article-title":"Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes","volume":"32","author":"Smith","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2014.11.006_bib30","first-page":"691","article-title":"GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6\u201314) analog","volume":"46","author":"Schuhmacher","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib31","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2967\/jnumed.109.064808","article-title":"Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide","volume":"50","author":"Sosabowski","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2014.11.006_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nucmedbio.2007.01.004","article-title":"In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer","volume":"34","author":"Sabbah","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2014.11.006_bib33","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1007\/s00259-010-1388-2","article-title":"A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues","volume":"37","author":"Schroeder","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.apradiso.2014.11.006_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/ci00063a006","volume":"29","author":"Viswanadhan","year":"1989","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.apradiso.2014.11.006_bib35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-10-1186","article-title":"Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)","volume":"71","author":"Wild","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.apradiso.2014.11.006_bib36","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1158\/0008-5472.CAN-03-3845","article-title":"Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804314003911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804314003911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T21:23:44Z","timestamp":1538083424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804314003911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":36,"alternative-id":["S0969804314003911"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2014.11.006","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2014.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}